Suryavanshi, M
In December 2025, Eli Lilly announced topline results from the phase-3 TRIUMPH-4 clinical trial evaluating the safety and efficacy of retatrutide in adults with obesity or overweight and knee osteoarthritis, and without diabetes, as an adjunct to healthy diet and physical activity.
Many GPCRs, including GLP-1R and GIPR, couple to the stimulatory G protein, Gs, to activate adenylyl cyclase and produce the second messenger cyclic AMP
En general, muchos destacan su efectividad en la mejora del rendimiento fsico y el apoyo en procesos de quema de grasa
Toxicol Appl Pharm 293:4452 Westermann D, Lettau O, Sobirey M, Riad A, Bader M, Schultheiss HP, Tschpe C
Los investigadores presentaron los detalles de los ensayos clnicos durante la reunin anual de la Asociacin Americana de la Diabetes, celebrada en New Orleans